Medicine and Dentistry
Neoplasm
100%
Connective Tissue Cancer
54%
Melanoma
39%
Malignant Neoplasm
36%
Soft Tissue Sarcoma
27%
Metastatic Carcinoma
23%
Diseases
21%
Immunity
15%
Recurrent Disease
14%
Overall Survival
14%
Cancer
14%
Biological Marker
13%
Malignant Peripheral Nerve Sheath Tumor
13%
Desmoid Tumor
13%
Immunohistochemistry
12%
Gastrointestinal Stromal Tumor
11%
Next Generation Sequencing
10%
Radiation Therapy
10%
Leiomyosarcoma
10%
Immunotherapy
10%
Liposarcoma
10%
Angiosarcoma
10%
Osteosarcoma
9%
Surgery
9%
Diagnosis
9%
Primary Tumor
9%
Pathologist
9%
Dedifferentiated Liposarcoma
9%
Immune Checkpoint Blockade
8%
Synovial Sarcoma
8%
Targeted Therapy
7%
Tumor Cell
7%
Protein P53
7%
Tissue Microarray
7%
Clinical Trial
7%
Metastatic Melanoma
7%
The Cancer Genome Atlas
6%
Ewing Sarcoma
6%
Well Differentiated Liposarcoma
6%
Catenin
6%
Oncology
6%
Epidermal Growth Factor Receptor
6%
Progression Free Survival
6%
Disease Specific Survival
6%
T Cell
6%
Sarcoma Cell
5%
Melanoma Skin Cancer
5%
In Vitro
5%
Gene Mutation
5%
Hazard Ratio
5%
Keyphrases
Tumor
38%
Soft Tissue Sarcoma
22%
Melanoma
20%
Sarcoma
20%
Pan-cancer Analysis
15%
Whole Genome
14%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
12%
Dedifferentiated Liposarcoma (DDLPS)
10%
In Cancer
9%
Overall Survival
9%
Cancer Genome Atlas
9%
Gastrointestinal Stromal Tumor
9%
Metastatic Melanoma
9%
Undifferentiated Pleomorphic Sarcoma
9%
Immunohistochemistry
9%
Synovial Sarcoma
8%
Desmoid Tumor
8%
Cancer Types
8%
Leiomyosarcoma
8%
Neoadjuvant
8%
Human Cancer
8%
Tissue Microarray
7%
Protein Expression
7%
Pan-cancer
7%
Clinical Outcomes
6%
High Risk
6%
Targeted Therapy
6%
Angiosarcoma
6%
Tumor Subtype
6%
Immune Checkpoint Blockade
6%
Metastasis
6%
Local Recurrence
5%
Disease-specific Survival
5%
Proteogenomics
5%
CTNNB1
5%
Molecular Features
5%
Next-generation Sequencing
5%
Liposarcoma
5%
Catenin
5%
Chemotherapy
5%
Putative Drug Targets
5%
Primary Tumor
5%